This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nemerson, Y. Search for Related Content PubMed PubMed Citation Articles by Nemerson, Y.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1369.)
© 2002 American Heart Association, Inc.

Editorials

A Simple Experiment and a Weakening Paradigm

The Contribution of Blood to Propensity for Thrombus Formation

Yale Nemerson

From the Department of Molecular Medicine, Mount Sinai School of Medicine, Annenberg, New York.

Correspondence to Dr Yale Nemerson, Division of Thrombosis Research, Department of Medicine, Mount Sinai School of Medicine, 1 Gustave Levey Pl, Box 1269, Annenberg, NY 10029-6504. E-mail Yale.Nemerson@mssm.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

For many years, arterial thrombosis was considered a result of vascular injury combined with a "normal" response of circulating coagulation factors and formed elements. Indeed, the original articles describing tissue factor in atherosclerotic lesions^1,2 implied that rupture or erosion of the plaque that results in contact of the circulating blood with plaque-bound tissue factor is sufficient to result in thrombus formation. These formulations ignore the fact that thrombi have been observed to occlude an artery within minutes of vascular perturbations.³ In retrospect, the role assigned to lesion-bound tissue factor is not physically realistic. The implied mechanism of thrombus growth is that surface-bound tissue factor rapidly binds circulating factor VII/VIIa, thereby forming the catalytic complex that proteolytically activates factors IX and X, thereby generating procoagulant intermediates that lead to thrombin production. This necessarily involves the diffusion of these intermediates from surface-bound tissue factor to platelets, where they form the catalytic complexes that directly generate thrombin from prothrombin. While on a microscopic level, these events are certainly accurate; occlusive thrombi are macroscopic structures that can rapidly grow to 3 mm. Consider that a protein of 50 kDa, typical of procoagulant intermediates, would, on average, take some 3 hours to diffuse 1 mm through water. In reality, the diffusion would be obstructed by adherent platelets and fibrin, which would reduce further the effective diffusion rate of these proteins.

See pages 1495

This reasoning led us to examine more closely the participation of blood components in thrombus propagation. Using ex vivo and in vitro . . . [Full Text of this Article]

This article has been cited by other articles:

				B. Bakouboula, O. Morel, A. Faure, F. Zobairi, L. Jesel, A. Trinh, M. Zupan, M. Canuet, L. Grunebaum, A. Brunette, et al. Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 536 - 543. [Abstract] [Full Text] [PDF]

				O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, F. Dignat-George, and J.-M. Freyssinet Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2594 - 2604. [Abstract] [Full Text] [PDF]

				R. Virmani, A. P. Burke, A. Farb, and F. D. Kolodgie Pathology of the vulnerable plaque. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C13 - C18. [Abstract] [Full Text] [PDF]